Who invested in Boundless Bio?
Boundless Bio's investors include ARCH Venture Partners, City Hill Ventures, RA Capital Management, Fidelity and Wellington Management, and 6 more on record.
United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$146Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $100M sold, first sale Apr 2023
From Boundless Bio's own website and the SEC filings it signed: 6 on the team.
On the board, as filediBenjamin D. CravattChristine D. BrennanFabio D. PucciJakob D. LovenJonathan D. LimKristina D. Burow
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Boundless Bio's investors include ARCH Venture Partners, City Hill Ventures, RA Capital Management, Fidelity and Wellington Management, and 6 more on record.
Boundless Bio has raised $146M across 2 rounds since 2019.
Boundless Bio's most recent round was a Series C of $100M in May 2023.
Its most recent round, $100M in May 2023, is also its largest on record.
Boundless Bio's first round on record, in Sept 2019, was backed by ARCH Venture Partners, City Hill Ventures and Vertex Ventures China and 3 others.
Boundless Bio's latest named round is a Series C, in May 2023.
Boundless Bio is based in the United States.
ARCH Venture Partners led the Series A in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.